AKYA(Delisted)
Akoya BiosciencesยทNASDAQ
--
--(--)
AKYA fundamentals
Akoya Biosciences (AKYA) expects to report earnings on Aug 4, 2025, with estimated revenue of 19.40M (YoY -16.38%), and EPS at -0.22 (YoY +18.52%).
Revenue estimate / YoY
19.40M
-16.38%
EPS estimate / YoY
-0.22
+18.52%
Report date
Aug 4, 2025
EPS
Revenue
Revenue & Expenses
AKYA has released its 2025 Q1 earnings report, with revenue of 16.64M, reflecting a YoY change of -9.32%, and net profit of -15.65M, showing a YoY change of 33.35%. The Sankey diagram below clearly presents AKYA's revenue sources and cost distribution.
Key Indicators
Akoya Biosciences (AKYA) key financial stats and ratios, covering profitability, financial health, and leverage.
Akoya Biosciences (AKYA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Akoya Biosciences (AKYA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Akoya Biosciences (AKYA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Akoya Biosciences (AKYA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Akoya Biosciences (AKYA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
